225 related articles for article (PubMed ID: 27448303)
21. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase.
Duan D; Zhang B; Yao J; Liu Y; Sun J; Ge C; Peng S; Fang J
Free Radic Biol Med; 2014 Apr; 69():15-25. PubMed ID: 24407164
[TBL] [Abstract][Full Text] [Related]
22. Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells.
Wen C; Huang L; Chen J; Lin M; Li W; Lu B; Rutnam ZJ; Iwamoto A; Wang Z; Yang X; Liu H
Int J Oncol; 2015 Nov; 47(5):1663-71. PubMed ID: 26397804
[TBL] [Abstract][Full Text] [Related]
23. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.
Huang GM; Sun Y; Ge X; Wan X; Li CB
World J Gastroenterol; 2015 May; 21(20):6194-205. PubMed ID: 26034354
[TBL] [Abstract][Full Text] [Related]
24. Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells.
Chen J; Gu HY; Lu N; Yang Y; Liu W; Qi Q; Rong JJ; Wang XT; You QD; Guo QL
Life Sci; 2008 Jul; 83(3-4):103-9. PubMed ID: 18586278
[TBL] [Abstract][Full Text] [Related]
25. GPR108 is required for gambogic acid inhibiting NF-κB signaling in cancer.
Lyu S; Zhang X; Tu Z; Zhou H; Ke X; Qu Y
Pharmacol Res; 2022 Aug; 182():106279. PubMed ID: 35659621
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of action of quercetin in cancer: recent advances.
Kashyap D; Mittal S; Sak K; Singhal P; Tuli HS
Tumour Biol; 2016 Oct; 37(10):12927-12939. PubMed ID: 27448306
[TBL] [Abstract][Full Text] [Related]
27. Studies on gambogic acid (IV): Exploring structure-activity relationship with IκB kinase-beta (IKKβ).
Sun H; Chen F; Wang X; Liu Z; Yang Q; Zhang X; Zhu J; Qiang L; Guo Q; You Q
Eur J Med Chem; 2012 May; 51():110-23. PubMed ID: 22472167
[TBL] [Abstract][Full Text] [Related]
28. Gambogic acid enhances the radiosensitivity of human esophageal cancer cells by inducing reactive oxygen species via targeting Akt/mTOR pathway.
Yang Y; Sun X; Yang Y; Yang X; Zhu H; Dai S; Chen X; Zhang H; Guo Q; Song Y; Wang F; Cheng H; Sun X
Tumour Biol; 2016 Feb; 37(2):1853-62. PubMed ID: 26318432
[TBL] [Abstract][Full Text] [Related]
29. Mangiferin in cancer chemoprevention and treatment: pharmacokinetics and molecular targets.
Rajendran P; Rengarajan T; Nandakumar N; Divya H; Nishigaki I
J Recept Signal Transduct Res; 2015 Feb; 35(1):76-84. PubMed ID: 24984103
[TBL] [Abstract][Full Text] [Related]
30. Global profiling of cellular targets of gambogic acid by quantitative chemical proteomics.
Zhou Y; Li W; Zhang X; Zhang H; Xiao Y
Chem Commun (Camb); 2016 Nov; 52(97):14035-14038. PubMed ID: 27853763
[TBL] [Abstract][Full Text] [Related]
31. Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma.
Liu L; Qi XJ; Zhong ZK; Zhang EN
Biomed Pharmacother; 2016 Oct; 83():79-84. PubMed ID: 27470553
[TBL] [Abstract][Full Text] [Related]
32. Nanoscale Features of Gambogic Acid Induced ROS-Dependent Apoptosis in Esophageal Cancer Cells Imaged by Atomic Force Microscopy.
Liu J; Fan S; Xiang Y; Xia J; Jin H; Xu JF; Yang F; Cai J; Pi J
Scanning; 2022; 2022():1422185. PubMed ID: 35937670
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.
Zou ZY; Wei J; Li XL; Yu LX; Wang TT; Qian XP; Liu BR
Cancer Biother Radiopharm; 2012 Jun; 27(5):299-306. PubMed ID: 22444164
[TBL] [Abstract][Full Text] [Related]
34. Gambogic acid inhibits the growth of osteosarcoma cells in vitro by inducing apoptosis and cell cycle arrest.
Zhao W; Zhou SF; Zhang ZP; Xu GP; Li XB; Yan JL
Oncol Rep; 2011 May; 25(5):1289-95. PubMed ID: 21331449
[TBL] [Abstract][Full Text] [Related]
35. Proteomic and bioinformatic analyses of possible target-related proteins of gambogic acid in human breast carcinoma MDA-MB-231 cells.
Li D; Song XY; Yue QX; Cui YJ; Liu M; Feng LX; Wu WY; Jiang BH; Yang M; Qu XB; Liu X; Guo DA
Chin J Nat Med; 2015 Jan; 13(1):41-51. PubMed ID: 25660287
[TBL] [Abstract][Full Text] [Related]
36. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes.
Yang Y; Yang L; You QD; Nie FF; Gu HY; Zhao L; Wang XT; Guo QL
Cancer Lett; 2007 Oct; 256(2):259-66. PubMed ID: 17693016
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous determination and pharmacokinetic study of gambogic acid and gambogenic acid in rat plasma after oral administration of Garcinia hanburyi extracts by LC-MS/MS.
Hua X; Liang C; Dong L; Qu X; Zhao T
Biomed Chromatogr; 2015 Apr; 29(4):545-51. PubMed ID: 25159917
[TBL] [Abstract][Full Text] [Related]
38. Studies on chemical modification and biology of a natural product, gambogic acid (III): determination of the essential pharmacophore for biological activity.
Wang X; Lu N; Yang Q; Gong D; Lin C; Zhang S; Xi M; Gao Y; Wei L; Guo Q; You Q
Eur J Med Chem; 2011 Apr; 46(4):1280-90. PubMed ID: 21334116
[TBL] [Abstract][Full Text] [Related]
39. Emerging tendencies for the nano-delivery of gambogic acid: a promising approach in oncotherapy.
Fahmy SA; Elghanam R; Rashid G; Youness RA; Sedky NK
RSC Adv; 2024 Jan; 14(7):4666-4691. PubMed ID: 38318629
[TBL] [Abstract][Full Text] [Related]
40. Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy.
Ding Y; Wang Y; Opoku-Damoah Y; Wang C; Shen L; Yin L; Zhou J
Biomaterials; 2015 Dec; 72():90-103. PubMed ID: 26344366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
